← Leaderboards
Charles Haines
Idbiologics, Llc
$1,911,648
Attributed
$1,911,648
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2020–23$2M$1.5M$1M$500K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$1,911,648 · 1
By mechanism
N01$1,911,648 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Antibody Therapy”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Yunda Huang · Fred Hutchinson Cancer Center$52,997,596
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420
- Thomas Denny · Duke University$22,999,550
- Arnab Kumar Chatterjee · Washington University$22,541,385
Research focus
Antibody TherapyChildEnterovirusEnterovirus 68InfectionMonoclonal AntibodiesPediatric ResearchPreventionTherapeutic Development
Grant awards (3)
Monoclonal Antibodies for the Treatment and Prevention of Enterovirus EV-D68 Infection$113,583
N01 · FY2023 · AI · contact PI
Monoclonal antibodies for the Treatment and Prevention of Enterovirus EV-D68 Infection$1,499,394
N01 · FY2021 · AI · contact PI
Monoclonal antibodies for the Treatment and Prevention of Enterovirus EV-D68 Infection$298,671
N01 · FY2020 · AI · contact PI